These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 11115955

  • 1. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol.
    Heredia A, Davis C, Redfield R.
    J Acquir Immune Defic Syndr; 2000 Nov 01; 25(3):246-55. PubMed ID: 11115955
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP, Nandy P, Avramis VI.
    In Vivo; 2000 Nov 01; 14(3):377-88. PubMed ID: 10904870
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the sensitivities of primary isolates of HIV type 2 and HIV type 1 to antiviral drugs and drug combinations.
    Cox SW, Apéria K, Albert J, Wahren B.
    AIDS Res Hum Retroviruses; 1994 Dec 01; 10(12):1725-9. PubMed ID: 7888232
    [Abstract] [Full Text] [Related]

  • 4. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
    Gao WY, Shirasaka T, Johns DG, Broder S, Mitsuya H.
    J Clin Invest; 1993 May 01; 91(5):2326-33. PubMed ID: 8387546
    [Abstract] [Full Text] [Related]

  • 5. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.
    Lori F, Malykh A, Cara A, Sun D, Weinstein JN, Lisziewicz J, Gallo RC.
    Science; 1994 Nov 04; 266(5186):801-5. PubMed ID: 7973634
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of HIV infection of resting peripheral blood lymphocytes by nucleosides.
    Watson AJ, Wilburn LM.
    AIDS Res Hum Retroviruses; 1992 Jul 04; 8(7):1221-7. PubMed ID: 1325818
    [Abstract] [Full Text] [Related]

  • 7. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
    Johnson VA, Merrill DP, Videler JA, Chou TC, Byington RE, Eron JJ, D'Aquila RT, Hirsch MS.
    J Infect Dis; 1991 Oct 04; 164(4):646-55. PubMed ID: 1716649
    [Abstract] [Full Text] [Related]

  • 8. A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215.
    Rusconi S, La Seta Catamancio S, Sheridan F, Parker D.
    J Clin Virol; 2000 Dec 04; 19(3):135-42. PubMed ID: 11090748
    [Abstract] [Full Text] [Related]

  • 9. The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds.
    Brennan TM, Taylor DL, Bridges CG, Leyda JP, Tyms AS.
    Antiviral Res; 1995 Mar 04; 26(2):173-87. PubMed ID: 7541619
    [Abstract] [Full Text] [Related]

  • 10. Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.
    Mayers DL, Japour AJ, Arduino JM, Hammer SM, Reichman R, Wagner KF, Chung R, Lane J, Crumpacker CS, McLeod GX.
    Antimicrob Agents Chemother; 1994 Feb 04; 38(2):307-14. PubMed ID: 8192457
    [Abstract] [Full Text] [Related]

  • 11. Didanosine and zidovudine resistance patterns in clinical isolates of human immunodeficiency virus type 1 as determined by a replication endpoint concentration assay.
    McLeod GX, McGrath JM, Ladd EA, Hammer SM.
    Antimicrob Agents Chemother; 1992 May 04; 36(5):920-5. PubMed ID: 1510414
    [Abstract] [Full Text] [Related]

  • 12. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
    Perez-Olmeda M, Garcia-Perez J, Mateos E, Spijkers S, Ayerbe MC, Carcas A, Alcami J.
    J Med Virol; 2009 Feb 04; 81(2):211-6. PubMed ID: 19107982
    [Abstract] [Full Text] [Related]

  • 13. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
    Shirasaka T, Yarchoan R, O'Brien MC, Husson RN, Anderson BD, Kojima E, Shimada T, Broder S, Mitsuya H.
    Proc Natl Acad Sci U S A; 1993 Jan 15; 90(2):562-6. PubMed ID: 8380641
    [Abstract] [Full Text] [Related]

  • 14. Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir.
    Hossain MM, Coull JJ, Drusano GL, Margolis DM.
    Antiviral Res; 2002 Jul 15; 55(1):41-52. PubMed ID: 12076750
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
    Dutschman GE, Bridges EG, Liu SH, Gullen E, Guo X, Kukhanova M, Cheng YC.
    Antimicrob Agents Chemother; 1998 Jul 15; 42(7):1799-804. PubMed ID: 9661024
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group.
    Larder BA, Kohli A, Bloor S, Kemp SD, Harrigan PR, Schooley RT, Lange JM, Pennington KN, St Clair MH.
    J Virol; 1996 Sep 15; 70(9):5922-9. PubMed ID: 8709213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.